Finance

Lists
FBIO:NASDAQ
Fortress Biotech Inc
$2.93
-1.68%
(-0.050) 1D
$2.98
+1.61% (+0.047)
After hours
Closed: Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIO...
Open
$2.92
High
$3.02
Low
$2.71
Mkt. cap
97.33M
Avg. vol.
692.59K
Volume
1.03M
P/E ratio
0.92
52-wk high
$4.53
52-wk low
$1.97
EPS
$3.18
Beta
1.21
Shares outstanding
33.22M
No. of employees
78
Open
$2.92
High
$3.02
Low
$2.71
Mkt. cap
97.33M
Avg. vol.
692.59K
Volume
1.03M
P/E ratio
0.92
52-wk high
$4.53
52-wk low
$1.97
EPS
$3.18
Beta
1.21
Shares outstanding
33.22M
No. of employees
78
News stories
From web sources and news partners
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorBiotechnology
Websitefortressbiotech.com
Analyst ratings
Based on 1 analyst giving stock ratings to FBIO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for FBIO in the last 3 months
Highest
Current $2.93
$5.00 (+70.65%)
Average
$5.00 (+70.65%)
Lowest
$5.00 (+70.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Maintained
$5.00
+70.6%
05/18/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$17.00
+480.2%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.63M
16.08M
16.04M
18.72M
Cost of goods sold
5.96M
5.07M
6.76M
-
Cost of revenue
5.96M
5.07M
6.76M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.42M
14.73M
15.89M
-
Operating expense
18.48M
15.80M
17.02M
-
Total operating expenses
24.44M
20.87M
23.78M
-
Operating income
-6.81M
-4.79M
-7.74M
-
Other non operating income
32.74M
5.00K
152.83M
-
EBT including unusual items
8.85M
-6.21M
142.29M
-
EBT excluding unusual items
23.93M
-6.19M
142.29M
-
Income tax expense
26.00K
-816.00K
5.13M
-
Effective tax rate
0.29%
13.13%
3.61%
-
Other operating expenses
-
-
-
-
Net income
5.85M
-3.94M
110.37M
-
Net profit margin
33.18%
-24.49%
688.20%
-
Earnings per share
-
-
-
-
Interest and investment income
736.00K
637.00K
570.00K
-
Interest expense
-2.74M
-2.04M
-3.37M
-
Net interest expenses
-2.01M
-1.40M
-2.80M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.65M
-3.63M
-6.52M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps